Bellerophon Therapeutics (NASDAQ:BLPH) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report report published on Monday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH opened at $0.04 on Monday. The firm has a market capitalization of $440,388.00, a PE ratio of -0.04 and […]
11 Oct 03:54 · The Cerbat Gem